Literature DB >> 21325112

The magnitude of acute serum creatinine increase after cardiac surgery and the risk of chronic kidney disease, progression of kidney disease, and death.

Areef Ishani1, David Nelson, Barbara Clothier, Tamara Schult, Sean Nugent, Nancy Greer, Yelena Slinin, Kristine E Ensrud.   

Abstract

BACKGROUND: Long-term outcomes after acute kidney injury remain poorly defined. We determined the association between the magnitude of creatinine increase after cardiac surgery and the risk of incident chronic kidney disease (CKD), CKD progression, and death.
METHODS: We identified 29,388 individuals who underwent cardiac surgery at Veterans Affairs hospitals between November 1999 and September 2005. The magnitude of creatinine increase was defined by the percent change from baseline to peak creatinine levels after cardiac surgery and categorized as none (≤0%) or as class I, (1%-24%), II (25%-49%), III (50%-99%), or IV (≥100%). Cox proportional hazard models were used to examine the association between the magnitude of creatinine increase and outcomes.
RESULTS: The relative hazards for outcomes increased monotonically with greater increases in creatinine levels compared with no change in creatinine levels. The relative hazards for adverse outcomes were significantly higher immediately after the creatinine increase and attenuated over time. Three months after surgery, creatinine increase classes I, II, III, and IV were associated with a greater risk of incident CKD (hazard ratios [HRs] 2.1, 4.0, 5.8, and 6.6, respectively; all P<.01), progression of CKD stage (HRs 2.5, 3.8, 4.4, and 8.0; all P<.01), and long-term mortality (HRs 1.4, 1.9, 2.8, and 5.0; all P<.01). At 5 years, the associations were lower in magnitude: incident CKD (HRs 1.4, 1.9, 2.3, and 2.3; all P<.01), CKD progression (HRs 1.5, 1.7, 1.7, and 2.4; all P<.01), and mortality (HRs 1.0, 1.2, 1.4, and 1.8; all P<.01, except class I).
CONCLUSION: The magnitude of creatinine increase after cardiac surgery is associated in a graded manner with an increased risk of incident CKD, CKD progression, and mortality. ©2011 American Medical Association. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21325112     DOI: 10.1001/archinternmed.2010.514

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  145 in total

Review 1.  Acute kidney injury in 2011: Biomarkers are transforming our understanding of AKI.

Authors:  Lakhmir S Chawla; John A Kellum
Journal:  Nat Rev Nephrol       Date:  2012-01-17       Impact factor: 28.314

2.  Association between peritransplant kidney injury biomarkers and 1-year allograft outcomes.

Authors:  Isaac E Hall; Mona D Doshi; Peter P Reese; Richard J Marcus; Heather Thiessen-Philbrook; Chirag R Parikh
Journal:  Clin J Am Soc Nephrol       Date:  2012-06-21       Impact factor: 8.237

3.  Incidence, determinants and impact of acute kidney injury in patients with diabetes mellitus and multivessel disease undergoing coronary revascularization: Results from the FREEDOM trial.

Authors:  Yaron Arbel; Valentin Fuster; Usman Baber; Taye H Hamza; F S Siami; Michael E Farkouh
Journal:  Int J Cardiol       Date:  2019-06-13       Impact factor: 4.164

4.  Empirical relationships among oliguria, creatinine, mortality, and renal replacement therapy in the critically ill.

Authors:  Tal Mandelbaum; Joon Lee; Daniel J Scott; Roger G Mark; Atul Malhotra; Michael D Howell; Daniel Talmor
Journal:  Intensive Care Med       Date:  2012-12-07       Impact factor: 17.440

5.  Influence of Mortality on Estimating the Risk of Kidney Failure in People with Stage 4 CKD.

Authors:  Pietro Ravani; Marta Fiocco; Ping Liu; Robert R Quinn; Brenda Hemmelgarn; Matthew James; Ngan Lam; Braden Manns; Matthew J Oliver; Giovanni F M Strippoli; Marcello Tonelli
Journal:  J Am Soc Nephrol       Date:  2019-09-20       Impact factor: 10.121

Review 6.  The proximal tubule is the primary target of injury and progression of kidney disease: role of the glomerulotubular junction.

Authors:  Robert L Chevalier
Journal:  Am J Physiol Renal Physiol       Date:  2016-05-18

7.  Adverse drug events during AKI and its recovery.

Authors:  Zachary L Cox; Allison B McCoy; Michael E Matheny; Gautam Bhave; Neeraja B Peterson; Edward D Siew; Julia Lewis; Ioana Danciu; Aihua Bian; Ayumi Shintani; T Alp Ikizler; Erin B Neal; Josh F Peterson
Journal:  Clin J Am Soc Nephrol       Date:  2013-03-28       Impact factor: 8.237

Review 8.  Chronic kidney disease following acute kidney injury-risk and outcomes.

Authors:  Kelvin C W Leung; Marcello Tonelli; Matthew T James
Journal:  Nat Rev Nephrol       Date:  2012-12-18       Impact factor: 28.314

9.  Minor Postoperative Increases of Creatinine Are Associated with Higher Mortality and Longer Hospital Length of Stay in Surgical Patients.

Authors:  Felix Kork; Felix Balzer; Claudia D Spies; Klaus-Dieter Wernecke; Adit A Ginde; Joachim Jankowski; Holger K Eltzschig
Journal:  Anesthesiology       Date:  2015-12       Impact factor: 7.892

10.  The incidence, risk factors, and outcomes of acute kidney injury in patients with pyogenic liver abscesses.

Authors:  Seong Eun Yun; Dae-Hong Jeon; Min Jeong Kim; Eun Jin Bae; Hyun Seop Cho; Se-Ho Chang; Dong Jun Park
Journal:  Clin Exp Nephrol       Date:  2014-08-05       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.